Optimized Monothiol Thioredoxin Derivative (ORP100S) Protects In Vitro and In Vivo from Radiation and Chemotoxicity Without Promoting Tumor Proliferation is a research paper published in Advanced Science (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: P30 CA014236
NIAID NIH HHS
Grant: U19 AI067798
NCI NIH HHS
Grant: R21 CA234701
National Heart, Lung and Blood Institute grant numbers
Grant: R43HL114132
National Heart, Lung and Blood Institute grant numbers
Grant: R56HL155582
National Institutes of Health grant numbers
Grant: UC6-AI058607
National Institute of Allergy And Infectious Diseases under Award Number
Grant: U01AI187020
NIAID NIH HHS
Grant: UC6 AI058607
NIAID NIH HHS
Grant: G20 AI167200
National Institutes of Health grant numbers
Grant: UC7-AI180254
U.S. Department of Defense PRMRP Technology/Therapeutics Development Award
Grant: W81XWH2210613
NHLBI NIH HHS
Grant: R44 HL140735
National Institutes of Health grant numbers
Grant: G20-AI167200
National Cancer Institute grant numbers
Grant: R21CA280499
NIAID NIH HHS
Grant: UC7 AI180254
NIAID NIH HHS
Grant: U01 AI150578
Cystic Fibrosis Foundation Therapeutics Development Award
MeSH Terms
Keywords